ID   COG-LL-329
AC   CVCL_B3TI
DR   Wikidata; Q110432730
RX   PubMed=19298590;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-329.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 13.2,15
ST   D21S11: 29,31.2
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 25,26
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M162 ! COG-LL-329h
OI   CVCL_B3TJ ! COG-LL-332
OI   CVCL_M163 ! COG-LL-332h
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
RX   PubMed=19298590; DOI=10.1111/j.1365-2141.2009.07631.x;
RA   Kang M.H., Harutyunyan N., Hall C.P., Papa R.A., Lock R.B.;
RT   "Methotrexate and aminopterin exhibit similar in vitro and in vivo
RT   preclinical activity against acute lymphoblastic leukaemia and
RT   lymphoma.";
RL   Br. J. Haematol. 145:389-393(2009).
//